CRLF2 and acute lymphoblastic leukemia: As previously reported for CRLF2 expression in BCP-ALL, [19] in order to define CRLF2 high-expressing (“CRLF2-high”) patients, the CIR hazard ratio was calculated for each unit increase in the CRLF2 expression expressed as fold change with respect to the median value.